We are a global leader in developing, manufacturing, selling and distributing innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. Our agents are routinely used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. Clinicians use our imaging agents and products across a range of imaging modalities including nuclear imaging, echocardiography and magnetic resonance imaging, or MRI. We believe that the resulting improved diagnostic information enables healthcare providers to better detect and characterize, or rule out, disease, potentially achieving improved patient outcomes, reducing patient risk and limiting overall costs for payers and the entire healthcare system. Our commercial products are used by nuclear physicians, cardiologists, radiologists, internal medicine physicians, technologists and sonographers working in a variety of clinical settings. We sell our products to radiopharmacies, hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations and, in certain circumstances, wholesalers. We sell our products globally and have operations in the United States, Puerto Rico, Canada and Australia and distribution relationships in Europe, Asia Pacific and Latin America.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
CT ORDER
Confidential treatment order
19 Mar 19
CT ORDER
Confidential treatment order
26 May 17
CT ORDER
Confidential treatment order
3 Apr 17
CT ORDER
Confidential treatment order
8 Jul 15
8-K
Other Events
22 Jun 15
8-K
Regulation FD Disclosure
9 Jun 15
10-Q
2015 Q1
Quarterly report
5 May 15
8-K
Lantheus Medical Imaging Reports 2015 First Quarter
5 May 15
8-K
Departure of Directors or Certain Officers
10 Apr 15
8-K
Departure of Directors or Certain Officers
16 Mar 15
Latest ownership filings
No filings